Latest News

Court Decision: Rejecting All Claims from Delta due to No Infringement made by Appotronics

SHENZHEN, China, Jan. 10, 2022 /PRNewswire/ -- Appotronics (688007.SH) announced onJanuary 6 that, according to two civil judgments (Case No. (2019) Jing73 Min Chu No. 1275 and Case No. (2019) Jing73 Min Chu No. 1276) from Beijing Intellectual Property Court received by Appotronics, it was decide...

2022-01-11 09:38 3000

Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy

SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- MicroStrategy , the US-based enterprise analytics platform, supportedPfizer, an American multinational pharmaceutical and biotechnology corporation, to usher in a future of sustainable data culture. With the help of solut...

2022-01-11 09:30 3173

Keep Your Home Safe and Build a Protected Community Against Omicron with Circle HealthPod

* Circle HealthPod detects >99.9% of known COVID-19 strains, including the Omicron variant, in approximately 20 minutes * With technology developed at the University of Oxford, the Circle HealthPod is a CE-IVD marked rapid detection system with 98.4% molecular accuracy * Frequent testing wit...

2022-01-11 09:00 3095

vivo Strengthens its Global Presence with User-oriented Innovation and Strategic Partnerships Designed to Inspire Joy

SHENZHEN, China, Jan. 11, 2022 /PRNewswire/ -- Global smartphone maker vivo has concluded an exceptional year, redoubling its efforts to deliver exciting new products and experiences to consumers around the world. In 2021, driven by its user-centered innovation strategy, vivo successfully launche...

2022-01-11 09:00 4562

Newgen Secures a Patent for Centralized Controlled Printing and Administration

- Patent to help enterprises in optimizing cost, and enabling anytime anywhere, secure, green printing SYDNEY, Jan. 11, 2022 /PRNewswire/ -- Newgen Software, a global provider of low code digital transformation platform , has announced that the Indian patent off...

2022-01-11 08:30 2655

Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of ASC42, An In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication

HANGZHOU, China and SHAOXING, China, Jan. 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC42 for chronic hepatitis B (CHB) indication. The Phase II clinical trial (ClinicalTrials.gov Identifier: NCT051...

2022-01-11 08:30 4044

Kognitiv Corporation promotes Peter Menges to EVP and Chief Commercial Officer

Seasoned executive brings Commercial focus to accelerate aggressive global growth TORONTO, Jan. 11, 2022 /PRNewswire/ -- Kognitiv Corporation, a global leader in the rapidly expanding market for collaborative commerce, announces the promotion ofPeter Menges to the role of EVP and Chief Commercia...

2022-01-11 08:30 2715

Proofpoint Completes the Acquisition of Dathena; Strengthens Enterprise Information Protection Offering

SUNNYVALE, Calif., Jan. 11, 2022 /PRNewswire/ -- Proofpoint, Inc. , a leading cybersecurity and compliance company, today announced it has completed its acquisition ofDathena , an innovator in artificial intelligence-powered data protection. ...

2022-01-11 08:00 2331

Xaxis Uses IAS's Context Control Targeting to Raise Awareness for a Fashion Brand

TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, and Xaxis, GroupM's outcome media specialist, used Context Control Targeting to increase campaign performance, website traffic, and brand awareness for a major fashion retailer, all ...

2022-01-11 08:00 3117

Dr. Ivan Puah Highlights The Significant Impact Of Covid That Changes Our Priority In Life

SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- The current pandemic has raised more awareness of the importance of health and better care of oneself. Dr.Ivan Puah, Medical Director at Amaris B. Clinic shares how people's lifestyles and priorities have changed since Covid-19 started. 01. Losing we...

2022-01-11 06:44 2537

Shopless: Predictions for the New Zealand Job Market in 2022

WELLINGTON, New Zealand, Jan. 11, 2022 /PRNewswire/ -- The future's looking bright for New Zealand job seekers in 2022. With the idea of "The Great resignation" being floated andNew Zealand moving to the traffic light system, what are the predictions for the job market as a whole? How is 2022 exp...

2022-01-11 06:18 3170

Constant Contact Agrees to Acquire Vision6

WALTHAM, Mass. and BRISBANE, Australia, Jan. 11, 2022 /PRNewswire/ -- Constant Contact , a digital marketing platform trusted by millions of small businesses, today announced it has signed a definitive agreement to acquireVision6 . The tr...

2022-01-11 06:01 2339

OneSmart International Education Group Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- OneSmart International Education Group Limited ("OneSmart" or the "Company") (NYSE: ONE) today announced that it received a notice from NYSE Regulation indicating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual a...

2022-01-11 05:30 5020

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

SEATTLE and SAN FRANCISCO and SAN JOSE, Calif. and NANJING, China and SUZHOU, China andSHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage ...

2022-01-11 05:30 3689

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

SEATTLE, SAN FRANCISCO, SAN JOSE, Calif., NANJING, China, SUZHOU, China and SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmace...

2022-01-11 05:30 4869

Customer experience pioneer, AskNicely, raises $32M to empower frontline teams to delight their customers

PORTLAND, Ore. and AUCKLAND, New Zealand, Jan. 10, 2022 /PRNewswire/ -- AskNicely , a leader in customer experience software for service businesses, announced today that it has completed a$32M Series B funding round and is launching the world's first Frontline Success P...

2022-01-11 05:00 2182

Analyzing the Arctic's Underwater Noise with AI: Evaluating Correlation between Climate Change, Sound and Marine Ecology

SAN JOSE, Calif., Jan. 10, 2022 /PRNewswire/ -- Arctic sea ice is a keystone indicator of greenhouse-gas induced global climate change, which is expected to be amplified in the Arctic. The underwater acoustic environment in the Arctic Ocean contains a great deal of unique insights such as behavio...

2022-01-11 01:00 2411

UAE convenes world leaders from policy, business and industry to take climate action and accelerate sustainable development

- Abu Dhabi Sustainability Week (ADSW) will host heads of state, more than 500 global speakers, 150 government ministers, 1,000 international businesses, and 3,000 students - UAE aims to accelerate pathways to net zero by mobilizing finance, innovation and partnerships ABU DHABI, UAE, Jan. 11, ...

2022-01-11 00:33 2498

SKF acquires additive manufacturing company

GOTHENBURG, Sweden, Jan. 11, 2022 /PRNewswire/ -- SKF has completed the acquisition of Laser Cladding Venture n.v. (LCV), an additive manufacturing company based inBelgium. LCV is a niche engineering start-up specialized in various additive manufacturing technologies and processes, which can be ...

2022-01-11 00:15 4670

Trajan Group acquires Neoteryx LLC

MELBOURNE, Australia, Jan. 10, 2022 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has completed the acquisition of Neoteryx, LLC (Neoteryx), a global leader in blood microsampling devices based inTorrance, California,...

2022-01-11 00:00 3296